Clarifications and Corrections
•Published: 00:01, 16 July 2026 | Updated: 00:01, 16 July 2026 An article about the trial of a new Ebola vaccine inaccurately said that the trial would inject people with Ebola.
•In fact, the vaccine candidate does not contain Ebola virus and no volunteers will be injected with Ebola.
•We apologise for any confusion.
هذا الخبر من Daily Mail. خبر يقدم أدوات ذكاء اصطناعي للتلخيص والترجمة والاستماع.
Published: 00:01, 16 July 2026 | Updated: 00:01, 16 July 2026 An article about the trial of a new Ebola vaccine inaccurately said that the trial would inject people with Ebola. In fact, the vaccine candidate does not contain Ebola virus and no volunteers will be injected with Ebola. We apologise for any confusion. To report an inaccuracy, please email corrections@mailonline.co.uk. To make a formal complaint under IPSO rules please go to www.mailonline.co.uk/readerseditor where you will find an easy-to-use complaints form. You can also write to Readers' Editor, Daily Mail, Northcliffe House, 9 Derry Street, London W8 5TT or contact IPSO directly at ipso.co.ukالمصدر: Daily Mail | Source: Daily Mail
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة Daily Mail. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by Daily Mail. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.
